Literature DB >> 10446067

Crystallization of free cholesterol in model macrophage foam cells.

G Kellner-Weibel1, P G Yancey, W G Jerome, T Walser, R P Mason, M C Phillips, G H Rothblat.   

Abstract

-The present study examined free cholesterol (FC) crystallization in macrophage foam cells. Model foam cells (J774 or mouse peritoneal macrophages [MPMs]) were incubated with acetylated low density lipoprotein and FC/phospholipid dispersions for 48 hours, resulting in the deposition of large stores of cytoplasmic cholesteryl esters (CEs). The model foam cells were then incubated for up to 5 days with an acyl-coenzyme A:cholesterol acyltransferase (ACAT) inhibitor (CP-113,818) in the absence of an extracellular FC acceptor to allow intracellular accumulation of FC. FC crystals of various shapes and sizes formed in the MPMs but not in the J774 macrophages. Examination of the MPM monolayers by microscopy indicated that the crystals were externalized rapidly after formation and thereafter continued to increase in size. Incubating J774 macrophages with 8-(4-chlorophenylthio)adenosine 3':5'-cyclic monophosphate (CPT-cAMP) in addition to CP-113,818 caused FC crystal formation as a consequence of CPT-cAMP stimulation of CE hydrolysis and inhibition of cell growth. In addition, 2 separate cholesterol phases (liquid-crystalline and cholesterol monohydrate) in the plane of the membrane bilayer were detected after 31 hours of ACAT inhibition by the use of small-angle x-ray diffraction of J774 macrophage foam cells treated with CPT-cAMP. Other compounds reported to inhibit ACAT, namely progesterone (20 microgram/mL) and N-acetyl-D-sphingosine (c(2)-ceramide, 10 microgram/mL), induced cellular toxicity in J774 macrophage foam cells and FC crystallization when coincubated with CPT-cAMP. Addition of the extracellular FC acceptors apolipoproteins (apo) E and A-I (50 microgram/mL) reduced FC crystal formation. In MPMs, lower cell density and frequent changes of medium were conducive to crystal formation. This may be due to "dilution" of apoE secreted by the MPMs and is consistent with our observation that the addition of exogenous apoE or apoA-I inhibits FC crystal formation in J774 macrophage foam cells cotreated with CP-113,818 plus CPT-cAMP. These data demonstrate that FC crystals can form from the hydrolysis of cytoplasmic stores of CEs in model foam cells. FC crystal formation can be modulated by the addition of extracellular FC acceptors or by affecting the cellular rate of CE hydrolysis. This process may contribute to the formation of FC crystals in atherosclerotic plaques.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10446067     DOI: 10.1161/01.atv.19.8.1891

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  33 in total

Review 1.  Consequences of cellular cholesterol accumulation: basic concepts and physiological implications.

Authors:  Ira Tabas
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

2.  ATR-101 inhibits cholesterol efflux and cortisol secretion by ATP-binding cassette transporters, causing cytotoxic cholesterol accumulation in adrenocortical carcinoma cells.

Authors:  Veronica Elizabeth Burns; Tom Klaus Kerppola
Journal:  Br J Pharmacol       Date:  2017-08-30       Impact factor: 8.739

3.  Trapping crystal nucleation of cholesterol monohydrate: relevance to pathological crystallization.

Authors:  Inna Solomonov; Markus J Weygand; Kristian Kjaer; Hanna Rapaport; Leslie Leiserowitz
Journal:  Biophys J       Date:  2004-12-13       Impact factor: 4.033

Review 4.  Immune effector mechanisms implicated in atherosclerosis: from mice to humans.

Authors:  Peter Libby; Andrew H Lichtman; Göran K Hansson
Journal:  Immunity       Date:  2013-06-27       Impact factor: 31.745

5.  Identification of cholesterol crystals in plaques of atherosclerotic mice using hyperspectral CARS imaging.

Authors:  Ryan S Lim; Jeffrey L Suhalim; Shinobu Miyazaki-Anzai; Makoto Miyazaki; Moshe Levi; Eric O Potma; Bruce J Tromberg
Journal:  J Lipid Res       Date:  2011-09-23       Impact factor: 5.922

6.  Cholesterol efflux analyses using stable isotopes and mass spectrometry.

Authors:  Robert J Brown; Fei Shao; Angel Baldán; Carolyn J Albert; David A Ford
Journal:  Anal Biochem       Date:  2012-10-13       Impact factor: 3.365

7.  Hydrated cholesterol: phospholipid domains probed by synchrotron radiation.

Authors:  I Solomonov; J Daillant; G Fragneto; K Kjaer; J S Micha; F Rieutord; L Leiserowitz
Journal:  Eur Phys J E Soft Matter       Date:  2009-10       Impact factor: 1.890

8.  Increased atherosclerosis in LDL receptor-null mice lacking ACAT1 in macrophages.

Authors:  S Fazio; A S Major; L L Swift; L A Gleaves; M Accad; M F Linton; R V Farese
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

9.  Properties of mixtures of cholesterol with phosphatidylcholine or with phosphatidylserine studied by (13)C magic angle spinning nuclear magnetic resonance.

Authors:  Richard M Epand; Alex D Bain; Brian G Sayer; Diana Bach; Ellen Wachtel
Journal:  Biophys J       Date:  2002-10       Impact factor: 4.033

10.  Neuronal loss of Drosophila NPC1a causes cholesterol aggregation and age-progressive neurodegeneration.

Authors:  Scott E Phillips; E A Woodruff; Ping Liang; Meaghan Patten; Kendal Broadie
Journal:  J Neurosci       Date:  2008-06-25       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.